Emergency intubation showdown: which method saves more oxygen?

NCT ID NCT07380763

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two ways to place a breathing tube in emergency patients who are still breathing on their own but need help. The methods are Rapid Sequence Intubation (RSI) and Delayed Sequence Intubation (DSI). Researchers will measure oxygen levels, complications, and survival in 140 adults. The goal is to find out which method is safer and more effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this trial succeeds, it could show which intubation method is safer and more effective for non-trauma patients, potentially improving emergency care guidelines.
What could go wrong
This is a single-center study with 140 participants, so results may not apply to all settings. The study is observational in nature and does not test a new drug or device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 18 years or older 2. Presence of spontaneous breathing. 3. No prediction of a difficult airway prior to intubation. 4. Requirement for advanced airway management. 5. Not in cardiac arrest. 6. Decided to intubate due to non-traumatic etiologies. 7. Planned intubation using ketamine for sedation and rocuronium for paralysis. 8. Decision to intubate due to one of the following clinical conditions: 1. Acute Respiratory Failure: Patients with hypoxic or hypercapnic respiratory failure where adequate oxygenation cannot be achieved despite non-invasive ventilation. 2. Inability to Protect the Airway: Altered level of consciousness or increased risk of pulmonary aspiration due to conditions such as upper gastrointestinal bleeding, ileus, volvulus, gastric outlet obstruction, hypersalivation, or hyperemesis. 3. Shock States: Patients in any state of shock (hypovolemic, distributive, cardiogenic, obstructive) exhibiting severe altered mental status or declining respiratory status. 4. Neuroprotection: Need to terminate ongoing seizures resistant to medical therapy (status epilepticus), or situations requiring strict control of arterial carbon dioxide (PaCO₂) levels to manage increased intracranial pressure (ICP) in non-traumatic conditions (such as intracranial hemorrhage or severe encephalopathy). 9. Obtaining informed consent from the patient or their legally authorized representative. Exclusion Criteria: 1. Aged under 18 years. 2. Pregnancy. 3. Refusal to provide informed consent. 4. Cardiac arrest prior to intubation. 5. Anticipated difficult airway. 6. Intubation required due to traumatic etiologies. 7. Missing or incomplete patient data. 8. Patients assigned to the DSI protocol but for whom the decision to intubate was rescinded due to clinical improvement during the preoxygenation phase. 9. Use of a sedative agent other than ketamine for the RSI protocol. 10. Intubations performed by practitioners who have not received study-specific training on DSI and RSI protocols. 11. Duplicate enrollment due to recurrent presentations during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Basaksehir Cam and Sakura City Hospital

    RECRUITING

    Istanbul, Istanbul, 34170, Turkey (Türkiye)

  • Kanuni Sultan Süleyman Research and Training Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • İstanbul Haseki Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • Şişli Hamidiye Etfal Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.